Abstract-In anesthetized cats, the administration of either bradykinin (BK) (0 .3-3 peg/kg) or prostaglandin E2 (PGE2) (1-30 /lg/kg) into the cranial mesenteric artery dose-dependently evoked the firing discharge in the proximal end of the afferent greater splanchnic nerves with a latency of about 10 sec, the pronounced con traction of the longitudinal muscle of the jejunum, and changes in blood pressure. PGE2 at the doses of 1-10 /cg/kg i.a. potentiated the BK (1 /cg/kg i.a.)-induced firing discharge of the afferent splanchnic nerves of which latency was also shortened, but did not alter the BK-induced jejunal contraction and blood pressure change. However, trimoprostil (30 iig/kg i.a.), a trimethyl PGE2 derivative, did not change all of these responses to BK. Aspirin at 50 mg/kg i.v. markedly prevented the BK induced nerve discharges, but not the BK-induced jejunal contraction . These results taken together indicate that PGE2 may be involved in the facilitatory response of afferent splanchnic nerve discharges to BK , but not involved in the BK-induced jejunal contraction and blood pressure change.
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The findings on trimoprostil present the possibility that derivatization of PGE2 could modify its inherent ability to produce adverse side-effects.
Prostaglandins
E1 and E2 (PGE1, PGE2) and their synthetic derivatives were highly effective in inhibiting gastric acid secretion and on protecting the gastric mucosa. However, these prostaglandins are known to cause abdominal pain (1-3), diarrhea (1, 3, 4), nausea and emesis (3, 4) in human subjects.
In addition to the well known potentiating effects of the PGE series on the action of pain-inducing substances (5-8), their direct intradermal or intra-articular injection also causes hyperalgesia (9, 10). Nevertheless , the effects of PGE2 on the abdominal pain model of animals have not been fully elucidated.
Trimoprostil (trimethyl PGE2) is known to inhibit gastric hypersecretion and lesion more than PGE2 and to elicit diarrhea less than PGE2 (11).
The present experiment was designed to determine whether the local injection of PGE2 and trimoprostil might elicit the affer ent splanchnic nerve discharge and jejunal contraction and interact with the effects of bradykinin (BK). intestinal motility, a strain-gauge arch (Nihon Koden, TH-612T) was sewn to the upper part of the jejunum in the area supplied by the cranial mesenteric artery. The left greater splanchnic nerve was exposed about 1.5 cm above the celiac ganglia, and the sheath was stripped off for the recording. The nerve was cut proximally, and the electrical activity was picked up by a bipolar platinum electrode and led into a dual beam oscilloscope (Nihon Koden, VC-9) and photographed on film with a polaroid camera. The signals were also stored on a TEAC R-410 data recorder for further analysis. The data were analyzed to determine the frequency of firing of units (spike/sec) during spontaneous activity and response to injections of bradykinin and prostaglandins with a Signal Processor (San ei, 7S06-A) and plotted by an X-Y recorder. Prostaglandin E2 (PGE2, Ono Pharma ceutical Co. Ltd.) and trimoprostil (11 R,16, 1 6-trimethyl-1 5R-hydroxy-9-oxoprostasis 5-trans-l3-dienoic acid, Hoffmann-La Roche) were dissolved in absolute ethanol to make a 10 mg/ml stock solution and then diluted with saline to make final concen trations of 30, 100, 300 and 1000 dig/ml. Bradykinin (BK, Protein Research Fundation, Osaka) was dissolved in saline to concen trations 10, 30 and 100 ,ag/ml. These drugs (0.3-30 fig/kg) were administered into the cranial mesenteric artery. To determine the potentiating effects of PGE2 or trimoprostil on BK-induced splanchnic nerve discharge, PGE2 or trimoprostil (1, 3, 10 dig/kg) was given together with BK (1 fig/kg) via the same cannula. Aspirin suspended in 0.1% carboxymethylcelIulose (CMC) solution was gradually administered into the femoral vein at 50 mg/kg.
Materials and Methods
The rate of increased firing integrated for each period of 30 sec was calculated from the difference between enhanced and control spike counts immediately before the intra arterial injection. The latency of the agent effect was determined as the time interval from the immediate time after intra-arterial injection of the agent to the time when spike counts reached over 150% of the mean pre administration value. The duration was determined as the time interval from the moment when firing increased to the time when spike counts returned to the pre administration value.
Results Effects of BK, PGE2 and trimoprostil on the activity of afferent splanchnic nerve and longitudinal jejunal contraction:
It was examined whether BK, PGE2 and trimoprostil might produce visceral pain, the effects of these compounds on the electrical activity of the afferent greater splanchnic nerves.
The administration of 0.03 ml/kg saline or 10% ethanol in saline (vehicle for both prostaglandins at the maximal dose) into the cranial mesenteric artery caused no changes in the slight background activity of the splanchnic nerve. The injection of BK (3 ,ug/kg i.a.) significantly (P<0.01, n=7) evoked a discharge in the greater splanchnic nerve with the increased firing rate of 366± 81% (integrated for the period of 30 sec), the latency of 10.4±1.2 sec and the duration of 38.7±2.8 sec; and it simultaneously induced the pronounced contraction of the upper part of the jejunal longitudinal muscle (Fig. 1, Table 1 ). BK (0.3-3.0 ug/kg i.a.) elicited a transient fall in femoral blood pressure followed by a 3 min rise in the blood pressure and heart rate.
The intra-arterial injection of PGE2 (30 fig/kg ) also evoked the splanchnic nerve discharge (the rate of increased firing was 262±42%, P<0.01, n=4), the jejunal con traction and a fall of blood pressure ac companied with tachycardia (Fig. 2, Table 1 ). However, trimoprostil (3-30 ag/kg i.a.) caused no changes in the nerve activity and intestinal motility, while the prostanoid slightly and transiently elevated blood pres sure (Fig. 3, Table 1 ).
Potentiating effects of PGE2 and tri moprostil on the BK-induced afferent splanchnic nerve discharges: PGE2 (land 3 ag/kg i.a.) did not produce any appreciable changes in the splanchnic nerve activities and cardiovascular parameters (Table 1) . However, the higher dose of 10 ,ug/kg i.a. of PGE2 slightly increased the firing rate (44.8±13.7%, P<0.1, n=4) and jejunal motility, and evoked a fall of blood pressure with tachycardia (Fig. 4, Table 1 ). These doses of PGE2 produced a potentiation of the BK (1 fig/kg i.a.)-induced excitatory action on the firing rate of the splanchnic nerve by 65.2±14.9% (P<0.1, n=9) (Fig. 4, Table 2 ) . The potentiating action of PGE2 was dose dependent (1-10 ag/kg i.a.). The mean control value for the latency of the nerve response to BK was 9.4±0.8 sec, while after the simultaneous administration of PGE2 at doses of 3 and 10 fig/kg i.a., latencies were significantly shortened to 6.6±1.5 sec (P<0.05, n=7) and 5.0±0.8 sec (P<0.01, n=6), respectively. Little change in the duration of the response to BK was found ( Table 2 ). The BK-induced cardiovascular changes and jejunal mctility were not sig nificantly affected with PGE2. On the other hand, the simultaneous administration of trimoprostil (30 ug/kg La.) did not change the BK-induced activation of the afferent splanchnic nerve discharge (Fig. 4, Table 2 ).
Effects of aspirin on BK-induced splanchnic nerve discharges and jejunal contraction: The effect of aspirin was examined on the BK-induced splanchnic nerve discharges and longitudinal jejunal contraction.
In 6 anes thetized cats, the pretreatment with aspirin (50 mg/kg i.v.) consistently decreased the splanchnic nerve discharge produced by the intraarterial administration of BK at 30, 60 and 120 min later (Fig. 5, Table 3 ), but did not alter the jejunal contraction (Fig. 6) . 
Discussion
BK has been known to possess strong algesic properties in the peripheral sites (12, 13). Nociceptive visceral messages induced by the injection of algogenic substances (BK, ACh) into the inferior mesenteric artery converge on dorsal horn cells receiving noxious cutaneous afferents in spinal cats (14). The splanchnic nerve includes the thin afferent fibers belonging to the Ad and C groups which conduct the splanchnic pain to the dorsal horn (15).
PGE2 causes abdominal pain in humans (2, 3). Many investigators have emphasized the involvement of prostaglandins in the production of pain, and the inhibition of their synthesis has been suggested as the mechanism by which aspirin produces analgesia (6, 7, 16, 17) . PG E, and PGE2 are known to enhance nociceptive responses by BK at the peripheral site (5, 6, 8, 18 ). The present investigation reveals that PGE2 at the large doses evokes multi-fiber activity in the afferent splanchnic nerves. The non effective small doses of PGE2 were found to enhance the BK-induced responses. However, PGE, and PGE2 are reported to have no effect on the central activity of nociceptive dorsal horn neurons (17) and on the excitatory nociceptive cardiac reflex (8, 16) . Therefore, the role of prostaglandins in the production of pain may be the sensitization of receptors to the effects of algesic agents rather than stimulating the receptors themselves.
The facilitatory response of the large doses of PGE2 may be due to the hypersensitization of receptors to the effects of all endogeneous algogenic substances such as BK, ACh, histamine, 5-hydroxy tryptamine, and substance P. It is also reported that BK facilitates the release of PGE-like substances, and this release is suppressed by aspirin-like drugs (8, 16, 19) . Furthermore, systemic adminis tration of aspirin abolished the BK-induced responses (5, 20) . It is of interest in the present finding that BK-induced afferent splanchnic nerve discharges were markedly decreased by the pretreatment with aspirin. These results indicate that the BK-induced abdominal pain may be mediated at least partly by prostaglandins. Lim et al. (20) reported that the injection of BK into the splenic artery elicited splanchnic nerve dis charges in the spinal cat and dog and vocalization in conscious dogs, which were blocked by aspirin and not by morphine. These findings taken together suggest that PGE2 is involved in these actions of BK. As for the activation of longitudinal jejunal contractility with PGE2 or BK, it is quite interesting to note that PGE2 does not potentiate the BK-induced contractility. Aspirin had no appreciable effect on the BK induced jejunal contraction.
These findings suggest that prostaglandins are not involved in the jejunal contraction caused with BK. PGE2 dose-dependently
(1-30 ug/kg La.) increased the amplitude of jejunal motility, whereas trimoprostil did not alter the jejunal motility. Indeed, PGE2 given p.o. to mice enhanced their intestinal transport of a food mixture and produced diarrhea more extensively than trimoprostil (11). The PGE series was reported to increase the jejunal pressure in vivo (24) 
